D.A. Davidson & Co. Quanterix Corp Transaction History

D.A. Davidson & Co.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$15.06 - $30.65 $108,432 - $220,680	-7,200 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$23.26 - $42.41 $656,769 - $1.2 Million	-28,236 Reduced 79.68%	7,200 $210,000
Q4 2021 Jan 31, 2022	SELL	$37.54 - $57.51 $40,130 - $61,478	-1,069 Reduced 2.93%	35,436 $1.5 Million
Q3 2021 Nov 15, 2021	BUY	$45.91 - $59.67 $181,436 - $235,815	3,952 Added 12.14%	36,505 $1.82 Million
Q2 2021 Aug 10, 2021	BUY	$43.3 - $67.17 $336,137 - $521,440	7,763 Added 31.32%	32,553 $1.91 Million
Q1 2021 May 07, 2021	BUY	$44.11 - $90.64 $16,585 - $34,080	376 Added 1.54%	24,790 $1.45 Million
Q4 2020 Feb 10, 2021	BUY	$33.89 - $49.88 $827,390 - $1.22 Million	24,414 New	24,414 $1.14 Million

155

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $388M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.